Smruthi Organics Limited (BOM:540686)

Market Cap	1.38B
Revenue (ttm)	1.20B
Net Income (ttm)	46.72M
Shares Out	11.45M
EPS (ttm)	4.07
PE Ratio	29.66
Forward PE	n/a
Dividend	1.50 (1.28%)
Ex-Dividend Date	Jun 13, 2025

Volume	4,864
Average Volume	4,077
Open	115.10
Previous Close	115.10
Day's Range	112.35 - 120.00
52-Week Range	103.00 - 164.00
Beta	-0.43
RSI	44.98
Earnings Date	Dec 26, 2025

About Smruthi Organics

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 267
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540686

Financial Performance

In 2024, Smruthi Organics's revenue was 1.26 billion, a decrease of -1.28% compared to the previous year's 1.28 billion. Earnings were 35.63 million, a decrease of -0.76%.